Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 15, 2023

SELL
$110.76 - $143.18 $11,076 - $14,318
-100 Reduced 2.22%
4,400 $493,000
Q2 2023

Aug 14, 2023

SELL
$126.43 - $145.6 $25,286 - $29,120
-200 Reduced 4.26%
4,500 $655,000
Q1 2023

May 15, 2023

BUY
$121.91 - $130.94 $572,977 - $615,418
4,700 New
4,700 $607,000
Q1 2022

May 16, 2022

SELL
$108.42 - $129.58 $227,682 - $272,118
-2,100 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$115.43 - $146.63 $46,172 - $58,652
-400 Reduced 16.0%
2,100 $269,000
Q3 2021

Nov 15, 2021

BUY
$136.35 - $158.76 $340,875 - $396,900
2,500 New
2,500 $367,000

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $23.1B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.